Company / Operating Margin
Altimmune, Inc. Operating Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-230461.0%
FY2025
5-year range
-230461.0% / 129029.4%
FY2021-FY2025
Trend
-923.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -923% YoY in FY2025, a notable deviation from the 9-year average annual change of +489%.
Based on SEC 10-K filings.
-230461.0% in FY2025 with a 5-year CAGR of -230091.0%.
Declined from 129029.4% to -230461.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -228263.4pp
- 5-Year Change
- -230091.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 923.4% year-over-year.
- Peak operating margin was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -230461.0% | -923.4% |
| FY2024 | -22518.5% | -117.5% |
| FY2023 | 129029.4% | +5971.4% |
| FY2022 | -2197.6% | -228.2% |
| FY2021 | -669.5% | -80.9% |
| FY2020 | -370.0% | +10.8% |
| FY2019 | -414.6% | +14.5% |
| FY2018 | -484.7% | -41.4% |
| FY2017 | -342.7% | -205.5% |
| FY2011 | -112.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026